Radiological-Pathological Analysis of WHO, RECIST, EASL, mRECIST and DWI: Imaging Analysis from a Prospective Randomized Trial of Y90 +/− Sorafenib

AIM: To compare radiological and pathological changes and test the adjunct efficacy of Sorafenib to Y90 as a bridge to transplantation in HCC. METHODS: 15 patients with 16 HCC lesions randomized to Y90 without (Group A, n=9) or with Sorafenib (Group B, n=7). Size (WHO, RECIST), enhancement (EASL, mR...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Hepatology
Main Authors: Vouche, Michael, Kulik, Laura, Atassi, Rohi, Memon, Khairuddin, Hickey, Ryan, Ganger, Daniel, Miller, Frank H., Yaghmai, Vahid, Abecassis, Michael, Baker, Talia, Mulcahy, Mary, Nayar, Ritu, Lewandowski, Robert J, Salem, Riad
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5097874/
https://ncbi.nlm.nih.gov/pubmed/23703789
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.26487
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados